Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
Oncogenic super-enhancers in cancer: mechanisms and therapeutic targets
CityU biologists discover super-enhancers tha
Prevalence and prognostic role of PIK3CA mutations. (a) Bar graph
Etiology of super-enhancer reprogramming and activation in cancer, Epigenetics & Chromatin
Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing
Prevalence and prognostic implications of molecular subtypes within
Defining super-enhancer landscape in triple-negative breast cancer by multiomic profiling
Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers
Nanomaterial-assisted CRISPR gene-engineering - A hallmark for triple-negative breast cancer therapeutics advancement. - Abstract - Europe PMC
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies - ScienceDirect
Cells, Free Full-Text
EphA2 super-enhancer promotes tumor progression by recruiting FOSL2 and TCF7L2 to activate the target gene EphA2
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers - Creative Proteomics
Cancers, Free Full-Text
Super-enhancer acquisition drives oncogene expression in triple negative breast cancer